129 related articles for article (PubMed ID: 22236417)
1. [Nondetectable prostate cancer in radical prostatectomy specimens].
Murányi M; Morshed AS; Benyó M; Tóth C; Flaskó T
Orv Hetil; 2012 Jan; 153(3):113-7. PubMed ID: 22236417
[TBL] [Abstract][Full Text] [Related]
2. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
3. Can pT0 stage of prostate cancer be predicted before radical prostatectomy?
Descazeaud A; Zerbib M; Flam T; Vieillefond A; Debré B; Peyromaure M
Eur Urol; 2006 Dec; 50(6):1248-52; discussion 1253. PubMed ID: 16828964
[TBL] [Abstract][Full Text] [Related]
4. Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy.
Mazzucchelli R; Barbisan F; Tagliabracci A; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
Virchows Arch; 2007 Apr; 450(4):371-8. PubMed ID: 17285325
[TBL] [Abstract][Full Text] [Related]
5. [Status and medicolegal implications in France pT0 stage of prostate cancer: a study by the CC-AFU].
Bessede T; Soulié M; Mottet N; Rebillard X; Peyromaure M; Ravery V; Salomon L;
Prog Urol; 2012 Dec; 22(16):1021-5. PubMed ID: 23178099
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of androgen deprivation therapy for localized prostate cancer: analysis of pT0 evaluated by radical prostatectomy specimen.
Kadono Y; Yaegashi H; Izumi K; Ueno S; Kitagawa Y; Mizokami A; Asahi H; Kobashi K; Koshida K; Namiki M
Anticancer Res; 2013 Mar; 33(3):1147-51. PubMed ID: 23482794
[TBL] [Abstract][Full Text] [Related]
7. Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.
Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Habuchi T; Ohyama C; Arai Y
BJU Int; 2013 May; 111(6):914-20. PubMed ID: 23320782
[TBL] [Abstract][Full Text] [Related]
8. Stage pT0 after radical prostatectomy with previous positive biopsy sets: a multicenter study.
Bessède T; Soulié M; Mottet N; Rebillard X; Peyromaure M; Ravery V; Salomon L;
J Urol; 2010 Mar; 183(3):958-62. PubMed ID: 20083270
[TBL] [Abstract][Full Text] [Related]
9. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
10. Outcome of radical prostatectomy for incidental carcinoma of the prostate.
Melchior S; Hadaschik B; Thüroff S; Thomas C; Gillitzer R; Thüroff J
BJU Int; 2009 Jun; 103(11):1478-81. PubMed ID: 19076134
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of nondetectable prostate carcinoma (pT0) after prolonged PSA-monitored neoadjuvant hormonal therapy followed by radical prostatectomy.
Köllermann J; Caprano J; Budde A; Weidenfeld H; Weidenfeld M; Hopfenmüller W; Helpap B
Urology; 2003 Sep; 62(3):476-80. PubMed ID: 12946750
[TBL] [Abstract][Full Text] [Related]
12. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
[TBL] [Abstract][Full Text] [Related]
13. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
[TBL] [Abstract][Full Text] [Related]
14. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
[TBL] [Abstract][Full Text] [Related]
16. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M
Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491
[TBL] [Abstract][Full Text] [Related]
17. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
[TBL] [Abstract][Full Text] [Related]
18. [Treatment results of radical prostatectomy in clinical stage B and C prostate cancer: comparison of the neoadjuvant therapy group versus the surgery group; retrospective analysis of 80 cases].
Ogura Y; Sakata Y; Wakita T; Hayashi N; Hioki T; Sugimura Y
Hinyokika Kiyo; 2003 Sep; 49(9):515-20. PubMed ID: 14598688
[TBL] [Abstract][Full Text] [Related]
19. pT0 prostate cancer after radical prostatectomy.
Gross JL; Masterson TA; Cheng L; Johnstone PA
J Surg Oncol; 2010 Sep; 102(4):331-3. PubMed ID: 20589707
[TBL] [Abstract][Full Text] [Related]
20. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]